Exploring the Impact of Extracorporeal Membrane Oxygenation on the Endothelium: A Systematic Review

• Published in: International journal of molecular sciences Vol. 25; no. 19; p. 10680
• Main Authors: Li, Yakun, Volleman, Carolien, Dubelaar, Dionne P C, Vlaar, Alexander P J, van den Brom, Charissa E
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01-10-2024; MDPI
• Subjects: Animals; Bias; Biomarkers; Blood oxygenation, Extracorporeal; Complications and side effects; Critical care medicine; Edema; endothelial activation; endothelial damage; Endothelium; Endothelium - metabolism; Endothelium, Vascular - metabolism; Extracorporeal membrane oxygenation; Extracorporeal Membrane Oxygenation - methods; glycocalyx; Health aspects; Humans; Laboratory animals; Methods; microvascular leakage; Patients; Permeability; Physiological aspects; Review; Systematic review; Vascular endothelium; Netherlands; glycocalyx; endothelium; microvascular leakage; edema; extracorporeal circulation; permeability; extracorporeal membrane oxygenation; endothelial damage; endothelial activation
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms251910680

Extracorporeal membrane oxygenation (ECMO) is a life-saving intervention for patients with circulatory and/or pulmonary failure; however, the rate of complications remains high. ECMO induces systemic inflammation, which may activate and damage the endothelium, thereby causing edema and organ dysfunction. Advancing our understanding in this area is crucial for improving patient outcomes during ECMO. The goal of this review is to summarize the current evidence of the effects of ECMO on endothelial activation and damage in both animals and patients. PubMed and Embase databases were systematically searched for both clinical and animal studies including ECMO support. The outcome parameters were markers of endothelial activation and damage or (in)direct measurements of endothelial permeability, fluid leakage and edema. In total, 26 studies (patient
= 16, animal
= 10) fulfilled all eligibility criteria, and used VA-ECMO (
= 13) or VV-ECMO (
= 6), or remained undefined (
= 7). The most frequently studied endothelial activation markers were adhesion molecules (ICAM-1) and selectins (E- and P-selectin). The levels of endothelial activation markers were comparable to or higher than in healthy controls. Compared to pre-ECMO or non-ECMO, the majority of studies showed stable or decreased levels. Angiopoietin-2, von Willebrand Factor and extracellular vesicles were the most widely studied circulating markers of endothelial damage. More than half of the included studies showed increased levels when compared to normal ranges, and pre-ECMO or non-ECMO values. In healthy animals, ECMO itself leads to vascular leakage and edema. The effect of ECMO support in critically ill animals showed contradicting results. ECMO support (further) induces endothelial damage, but endothelial activation does not, in the critically ill. Further research is necessary to conclude on the effect of the underlying comorbidity and type of ECMO support applied on endothelial dysfunction.